Table 3.
Lenalidomide dose in responding patients
| Lenalidomide, mg/d | Patients | CR | Nodular PR | PR |
|---|---|---|---|---|
| 5 | 3/11 | 3 | ||
| 10 | 4/16 | 1 | 3 | |
| 15 | 4/12 | 1 | 3 | |
| 20 | 1/2 | 1 | ||
| 25 | 2/3 | 1 | 1 |
CR indicates complete remission; and PR, partial remission.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.